Addiction is diagnosed through a clinical evaluation, not a blood test or brain scan. A qualified professional assesses your behavior patterns, substance use history, and the impact on your daily life, then measures those findings against a standardized checklist of 11 symptoms. If you meet at least two of those symptoms within a 12-month period, you receive a formal diagnosis of substance use disorder, with severity ranging from mild to severe depending on how many criteria you meet.
The 11 Symptoms That Define the Diagnosis
The current diagnostic standard comes from the DSM-5, the manual used by mental health professionals across the United States. It lists 11 criteria that apply across all substances, from alcohol to opioids to stimulants. These symptoms fall into four broad clusters: loss of control, social problems, risky use, and physical dependence.
Loss of control includes using more of a substance than you intended, wanting to cut back but being unable to, spending large amounts of time obtaining or recovering from the substance, and experiencing cravings. Social problems include failing to meet responsibilities at work, school, or home, continuing use despite relationship damage, and giving up activities you once enjoyed. Risky use means using in physically dangerous situations or continuing despite knowing it’s causing you physical or psychological harm. Physical dependence covers tolerance (needing more to get the same effect) and withdrawal symptoms when you stop.
You don’t need all 11. Two or three symptoms within 12 months qualifies as a mild substance use disorder. Four or five is moderate. Six or more is severe. This spectrum replaced the old system that drew a hard line between “abuse” and “dependence,” which often missed people in earlier stages.
What the Evaluation Actually Looks Like
A diagnosis typically comes from a psychiatrist, psychologist, or licensed alcohol and drug counselor. The process starts with a thorough interview about your substance use: what you use, how much, how often, when it started, and what happens when you try to stop. The clinician will also ask about your mental health history, family background, and how substance use has affected your relationships, job, and physical health.
In more formal settings, clinicians use structured interviews like the Structured Clinical Interview for DSM-5 (SCID-5). This is a semi-structured conversation that walks through each diagnostic criterion systematically, assesses age of onset, and determines whether a past disorder is currently active or in remission. The substance use module takes roughly 20 to 30 minutes to complete. Not every clinician uses a structured interview, but it ensures nothing gets missed and makes the diagnosis more consistent across providers.
Shorter screening tools often come first, especially in primary care. The Drug Abuse Screening Test (DAST-10) is a 10-question yes-or-no questionnaire that flags the severity of drug-related problems on a scale from “no problem” to “severe.” Similar tools exist for alcohol. These screeners aren’t diagnoses themselves. They’re designed to identify who needs a fuller evaluation.
Why Drug Tests Don’t Diagnose Addiction
This is a common point of confusion. A urine or blood test can confirm recent drug use, but it cannot tell a clinician whether someone has a substance use disorder. Drug tests offer objective evidence that a substance was used, which is useful for monitoring treatment progress or verifying what someone reports. But a positive result only means a drug was present in the body. It says nothing about the pattern of use, the loss of control, or the impact on someone’s life, which are the factors that actually define addiction.
A negative test isn’t fully reliable either. Timing, the specific substance, and the type of test all affect whether drug use shows up. Diagnosis is made through clinical history and behavioral symptoms, with lab results serving a supporting role at best.
Sorting Out Overlapping Mental Health Conditions
One of the trickiest parts of diagnosing addiction is figuring out whether psychiatric symptoms are caused by the substance use or exist independently alongside it. Alcohol and drugs can produce symptoms identical to depression, anxiety, psychosis, and other mental health conditions. Someone in heavy stimulant use might look like they have a psychotic disorder. Someone withdrawing from alcohol might look like they have severe anxiety.
Because of this overlap, mental health diagnoses made during active substance use are often considered provisional. Clinicians may need to wait weeks or months of abstinence before they can confidently say whether a co-occurring condition like depression is independent or substance-induced. This distinction matters because the treatment approach differs significantly. A substance-induced mood disorder may resolve once the substance use is addressed, while an independent disorder needs its own treatment plan.
How Severity and Treatment Level Are Determined
The DSM-5 symptom count gives a severity label, but treatment decisions require a fuller picture. The American Society of Addiction Medicine (ASAM) uses a six-dimension framework that goes well beyond substance use alone. It evaluates your current intoxication or withdrawal risk, any medical conditions, your emotional and cognitive state, your motivation for change, your history of relapse, and your living situation and social supports.
Someone with severe substance use disorder who has stable housing and strong motivation may need a different level of care than someone with moderate disorder who is homeless and has untreated trauma. The ASAM dimensions help match people to the right intensity of treatment, whether that’s outpatient counseling, intensive outpatient programs, or residential care.
Remission and How It’s Tracked
The diagnostic framework also defines what recovery looks like in clinical terms. Early remission means you’ve gone at least 3 months without meeting any substance use disorder criteria, with the exception of cravings, which can persist. Sustained remission starts at 12 months or more without meeting those criteria. Cravings are excluded from remission tracking because they can linger long after other symptoms resolve and don’t necessarily indicate active disorder.
This means a diagnosis isn’t permanent in the way people sometimes fear. The clinical label reflects your current state. As your pattern of behavior changes, the diagnosis updates to reflect that, moving from active disorder to early remission to sustained remission over time.
Brain Scans and the Future of Diagnosis
Researchers have spent decades studying how addiction changes the brain using imaging technology. These studies have confirmed that addiction involves real neurological changes in areas related to reward, decision-making, and impulse control. But despite this progress, brain imaging has not made it into routine clinical diagnosis. The field still relies on symptom-based checklists because no scan can reliably distinguish someone with a substance use disorder from someone without one in a clinical setting. The gap between what imaging reveals in research and what it can do at the bedside remains significant.